Miriam Kidron - 14 Mar 2023 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Chief Scientific Officer, Director
Signature
/s/ Miriam Kidron
Issuer symbol
ORMP
Transactions as of
14 Mar 2023
Net transactions value
-$201,000
Form type
4
Filing time
15 Mar 2023, 17:20:08 UTC
Previous filing
01 Aug 2022
Next filing
20 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Sale $201,000 -100,000 -33% $2.01 201,666 14 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to a company owned solely by Nadav Kidron, a director and the president and chief executive officer of the Issuer, and the Reporting Person used the proceeds in connection with a personal tax payment.